| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |